English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective This study aims to assess the efficacy of single-dose albendazole in treating mild, moderate, and severe ascariasis. Methods Stool specimens were collected from randomly selected elementary school children in Suka village, Sumatera Utara, from March to April 2002. Based on the number of eggs per gram feces (NEPG), samples were categorized as mild (NEPG 35,000) ascariasis. All subjects then received 400 mg albendazole orally. NEPG count was repeated on the 7th, 14th, 21st and 28th day after treatment. The chi-square test was used to compare cure rates between subjects with mild, moderate, and severe ascariasis. The ANOVA and Kruskal-Wallis tests were employed to analyze quantitative data. Results From the 134 specimens collected, we found mild ascariasis in 57 (42.5%), moderate ascariasis in 57 (42.5%), and severe ascariasis in 20 (15%). There was no significant difference between the three groups in NEPG after treatment (P>0.05). The cure rate and egg reduction rate on day 28 after treatment was 100%. Conclusion A single dose of 400 mg albendazole is effective for the treatment of mild, moderate, and severe ascariasis. [Paediatr Indones 2005;45:118-122].

The efficacy of single-dose albendazole for the treatment of ascariasis